News
One of the highlights of Eli Lilly's third-quarter results was the rapid uptake of new type 2 diabetes therapy Mounjaro, which added more than $97 million in US sales alone in what has been ...
The Eli Lilly drug caused a major drop in the blood ... During the trial, Mr. Wooden had no symptoms of heart disease — no chest pain, no breathlessness. When the trial ended, his symptoms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results